Positions
- Professor and Chair, Department of Surgery
-
Baylor College of Medicine
- DeBakey-Bard Chair of Surgery
-
Baylor College of Medicine
- Professor of Molecular & Cellular Biology
-
Baylor College of Medicine
- Vice President, Hospital Operations and Quality Improvement
-
Baylor College of Medicine
- Professor of Heart and Vascular Disease
-
The Texas Heart Institute at Baylor College of Medicine
Addresses
- Baylor St. Luke’s Medical Center (Clinic)
-
THI Outpatient Clinic
1101 Bates Avenue
Houston, TX, 77030
United States
Phone: (713) 798-1300
Education
- Clinical Fellowship at The New York Hospital
- New York
- Thoracic Surgery
- Research Fellowship at National Institutes of Health
- 01/1987 - Bethesda, MD, United States
- Residency at New York University Medical Center
- 01/1989 - New York, New York, United States
- General Surgery
- Internship at New York University Medical Center
- 01/1985 - New York, NY, United States
- General Surgery
- MD from Northwestern University
- 01/1983 - Chicago, IL, United States
Certifications
- Board Certified
- American Board of Surgery
- Board Certified
- American Board of Thoracic Surgery
Honors & Awards
- Texas “Super Doctor”
- 2019 – 2024
- Texas Monthly
- Top Doctors
- 2013 – 2020
- Houstonian Magazine
- Top Doctors
- 2004-2006
- Chicago Magazine
- Top Doctors
- 2007-2012
- New York Magazine
- America’s Top Doctors
- 3rd – 11th Edition
- Castle Connolly
- Distinguished Scientist Award
- 2017
- Baylor St. Luke’s Medical Center
Professional Interests
Professional Statement
Dr. Todd K. Rosengart, professor and chair of the Michael E. DeBakey Department of Surgery and DeBakey-Bard Chair of Surgery, is also professor of heart and vascular disease at the Texas Heart Institute and professor of molecular and cell biology at Baylor. He is an NIH-funded scientist with over $25 million in uninterrupted extramural funding since 1998, including his serving as PI of a renewed NIH T32 grant for research training in cardiovascular science. He is past president of the Society of Surgical Chairs, representing the academic chairs of surgery in North America, currently serves on the Executive Committee of the American College of Surgeons Board of Governors, and previously served as a member of the board of directors of the American Association for Thoracic Surgery, the world’s oldest society for cardiothoracic surgery. He was also recently elected into the National Academy of Inventors for his work in cardiovascular gene therapy.
Dr. Rosengart and his team at Cornell in 1997 performed the world’s first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved angiogenesis trial for “no option” patients with end stage coronary artery disease. This work led to the recent completion of a successful Phase 2 trial conducted under FDA Fast Track status conducted by XyloCor Therapeutics, co-founded by Rosengart in 2016. He holds 16 issued U.S. and other patents and is author of nearly 300 peer-reviewed articles and other publications with over 16,000 citations and an h-index of 67 (i10-index: 179). He has mentored nearly 100 research and cardiac surgery trainees.
Dr. Rosengart is past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section, chair of the American College of Surgeons National Surgeon Scientist Study Section, member of the Leducq Foundation Scientific Advisory Committee and a member of the American College of Surgeons Academy of Master Surgeon Educators. He is co-editor of the ACS Surgery Chairs Playbook and past editor of Seminars in Thoracic and Cardiovascular Surgery, serving since 2013. Amongst other affiliations, he is a member of the American Surgical Association and a fellow of the American College of Cardiology.
Dr. Rosengart’s institutional roles include that as chair of the Baylor St. Luke’s Medical Center (BSLMC) Hospital Operations Committee and his serving on the BCM Executive Leadership Team. He was recently appointed to the Board of Trustees of the Texas Heart Institute. He also served as two-term chair of the BCM Faculty Group Practice Board of Governors and as a member of the Baylor St. Luke’s Medical Center Board of Directors. He previously served as board chair of the Affiliated Medical Services, a 1000-member consortium of BCM and University of Texas faculty staffing the Harris Health county medical system, one of the largest in the US. He also previously served as national chair of the cardiac surgery service line for CHI (now Common Spirit), a 140-hospital not-for-profit organization with 40 cardiac surgery programs, the largest not-for-profit hospital system in the US.
Dr. Rosengart was co-founder of Vitals.com (MDx, LLC, which before its recent acquisition had become one of the world’s largest web-based medical consumerism companies, and founder of Aspira Medical, which is developing wearable ultrasound technology to provide early detection of critical human pathophysiology.
Dr. Rosengart and his team at Cornell in 1997 performed the world’s first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved angiogenesis trial for “no option” patients with end stage coronary artery disease. This work led to the recent completion of a successful Phase 2 trial conducted under FDA Fast Track status conducted by XyloCor Therapeutics, co-founded by Rosengart in 2016. He holds 16 issued U.S. and other patents and is author of nearly 300 peer-reviewed articles and other publications with over 16,000 citations and an h-index of 67 (i10-index: 179). He has mentored nearly 100 research and cardiac surgery trainees.
Dr. Rosengart is past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section, chair of the American College of Surgeons National Surgeon Scientist Study Section, member of the Leducq Foundation Scientific Advisory Committee and a member of the American College of Surgeons Academy of Master Surgeon Educators. He is co-editor of the ACS Surgery Chairs Playbook and past editor of Seminars in Thoracic and Cardiovascular Surgery, serving since 2013. Amongst other affiliations, he is a member of the American Surgical Association and a fellow of the American College of Cardiology.
Dr. Rosengart’s institutional roles include that as chair of the Baylor St. Luke’s Medical Center (BSLMC) Hospital Operations Committee and his serving on the BCM Executive Leadership Team. He was recently appointed to the Board of Trustees of the Texas Heart Institute. He also served as two-term chair of the BCM Faculty Group Practice Board of Governors and as a member of the Baylor St. Luke’s Medical Center Board of Directors. He previously served as board chair of the Affiliated Medical Services, a 1000-member consortium of BCM and University of Texas faculty staffing the Harris Health county medical system, one of the largest in the US. He also previously served as national chair of the cardiac surgery service line for CHI (now Common Spirit), a 140-hospital not-for-profit organization with 40 cardiac surgery programs, the largest not-for-profit hospital system in the US.
Dr. Rosengart was co-founder of Vitals.com (MDx, LLC, which before its recent acquisition had become one of the world’s largest web-based medical consumerism companies, and founder of Aspira Medical, which is developing wearable ultrasound technology to provide early detection of critical human pathophysiology.
Websites
@DrRosengart
IN THE NEWS
Selected Publications
-
Suliburk JW, Buck QM, Pirko CJ, Massarweh NN, Barshes NR, Singh H, Rosengart TK. " Analysis of human performance deficiencies associated with surgical adverse events " JAMA Netw Open. 2019 ;
Pubmed PMID: 3136510. -
Rosengart TK, Doherty G, Higgins R, Kibbe MR, Mosenthal AC. " Transition Planning for the Senior Surgeon: Guidance and Recommendations From the Society of Surgical Chairs " JAMA Surg. ;
Pubmed PMID: 31090889. -
LeMaire SA, Trautner BW, Ramamurthy U, Green SY, Zhang Q, Fisher WE, Rosengart TK. " An academic relative value unit system for incentivizing the academic productivity of surgery faculty members " Ann Surg. 2018 ;
Pubmed PMID: 30004925. -
Patel V, Cooney A, Flores ER, Singh V, Mathison M, Sanagasetti, D, Mullany LK, Crystal RG, Yang J, Rosengart TK. " p63 silencing enhances the reprogramming of cardiac fibroblasts into induced cardiomyocytes " J Thorac Cardiovasc Surg. 2018 ;
Pubmed PMID: 29716728.
Memberships
- Alpha Omega Alpha Honor Society
- American Association for Thoracic Surgery
- Board of Directors, Education Director
- American College of Surgeons
- Fellow, Research Committee
- ACS Academy of Master Surgeon Educators
- American Heart Association
- American Surgical Association
- Association of Academic Surgeons
- Senior Member
- Andrew Morrow Society of Cardiac Surgeons
- Seminars in Thoracic and Cardiovascular Surgery
- Editor-in-Chief (2012-2020)
- Society of Thoracic Surgeons
- Society of University Surgeons
- Society of Surgical Chairs
- President (2018-2019)
- Southern Thoracic Surgical Association
- Texas Surgical Society
- National Academy of Inventors
- Fellow
Languages
Spanish
Log In to edit your profile